Pharmacovigilance and Drug Safety Software Market by Functionality, Delivery Mode, End-user - Global Forecasts to 2019

DUBLIN, April 15, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/dwz9l5/pharmacovigilance) has announced the addition of the "Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019

North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. 

The growth of the global pharmacovigilance and drug safety software market is mainly driven by increasing incidence rates of adverse drug reactions (ADRs), growing adoption of pharmacovigilance software by outsourcing companies (such as CROs and BPOs), and huge pressure on pharma companies to develop novel and safe drugs. However, the dearth of standard regulations and lack of pharmacovigilance professionals are some of the key factors restraining the growth of this market. 

In this report, the global pharmacovigilance and drug safety software market has been classified into four segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. 

The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers. 

The global pharmacovigilance and drug safety software market comprises large number of small and mid-size software developers and service providers. As of 2014, the global pharmacovigilance and drug safety software market was dominated by Oracle Corporation (U.S.). 

New service launches; agreements, and partnerships; software developments; and geographical expansions are some of the major strategies adopted by most of the market players to achieve growth in the pharmacovigilance and drug safety software market. 

Key Topics Covered: 

1 Introduction 

2 Research Methodology 

3 Executive Summary 

4 Premium Insights 

5 Market Overview 

6 Industry Insights 

7 Pharmacovigilance and Drug Safety Software Market, By Functionality 

8 Pharmacovigilance and Drug Safety Software Market, By Delivery Mode 

9 Pharmacovigilance and Drug Safety Software Market, By End-Users 

10 Geographic Analysis 

11 Competitive Landscape 

12 Company Profiles

- AB-Cube 
- Arisglobal 
- Ennov. 
- Extedo GMBH. 
- Online Business Applications, Inc 
- Oracle Corporation. 
- Sarjen Systems Pvt. Ltd 
- Sparta Systems, Inc 
- Umbra Global 
- United Biosource Corporation 

For more information visit http://www.researchandmarkets.com/research/dwz9l5/pharmacovigilance

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets